CytRx Corporation (CYTR) is a biopharmaceutical company specializing in oncology. Its focus is on the discovery, research and clinical development of novel anti-cancer drug candidates that employ linker technologies to enhance the accumulation and release of drug at the tumor. CYTR: Get the latest CytRx stock price and detailed information including CYTR news, historical charts and realtime prices. CytRx Corporation (CYTR) ownership summary provides a high level overview of up-to-date institutional holdings and insider trades @fintel_io Also, if you are new to $CYTR here's a background article on Finpedia for you https://t.co/4scpYXxcoj November 16 th 2019, 1:11am CytRx Corporation's stock rating is based on fundamental analysis. Don't miss CYTR stock next rating changes
5 Jun 2017 Sabby Capital's Hal Mintz Flips CytRx Corporation (CYTR), Initiates Mannkind The fund has mainly healthcare stocks, in particular small-cap
60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. 5/2/2017 · SEC Fines CytRx $75,000 for paid promotion of stock, but with an apology, as promotion was not false or misleading. Adam Feuerstein of The Street maintains the drug is, and always was, a failure. CEO Steven Kriegsman keeps the blue-light-special dilutions rolling out each quarter. CYTR stock quote, chart and news. Get CytRx Corp.'s stock price today. CytRx has outlicensed aldoxorubicin to NantCell as of 2017. Stock promotion. In 2014 CytRx was involved in a stock promotion scheme, paying DreamTeamGroup US$65,000 to write at least 13 articles that appeared on Seeking Alpha, Forbes.com, Motley Fool, and Cheat Sheet. 6/3/2019 · View today's stock price, news and analysis for CytRx Corp. (CYTR). Barron's also provides information on historical stock ratings, target prices, company
22 May 2017 Cytrx Corp - CYTR Stock Chart Technical Analysis for 05-22-17 Subscribe to My MAIN Channel Here: https://www.youtube.com/claytrader/ Free
Shares of CYTR and GALE both quadrupled during an undisclosed paid promotion via Dream Team. Documents show that CYTR and GALE management edited, changed and ap Stock buybacks cannot be treated as returns to investors because public companies can rescind what they returned through dilution. Nejnovější tweety od uživatele StockWolf (@StockWolfCom). Stats & Numbers. For education only, not a recommendation to buy/sell/hold. Do your own DD. OTC only. Tweets are automated from data, not posted manually. Nejnovější tweety od uživatele Andrey V Tytchino (@atytchino). Investor in Real Estate, mortgage specialist and trader. Love discussing topics on various financial matters. Ottawa, Ontario Podívejte se na Twitteru na tweety k tématu #clnt. Přečtěte si, co říkají ostatní, a zapojte se do konverzace.